Raymond James & Associates’s Spectranetics Corp SPNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-20,843
Closed -$607K 3495
2017
Q1
$607K Buy
20,843
+7,014
+51% +$187K ﹤0.01% 2269
2016
Q4
$339K Buy
+13,829
New +$325K ﹤0.01% 2562
2015
Q3
Sell
-10,948
Closed -$252K 2440
2015
Q2
$252K Buy
+10,948
New +$306K ﹤0.01% 2324

Other funds holding SPNC

Raymond James & Associates's SPNC Position: Q2 2017 in Review

Raymond James & Associates sold out of Spectranetics Corp (SPNC) in Q2 2017, closing a stake of 20,843 shares — an estimated $607K sold.

Raymond James & Associates first reported a position in SPNC in Q2 2015 and held it in 3 quarters. The position peaked at $607K in Q1 2017. 170 funds tracked by Wall St. Rank hold SPNC as of Q2 2017.

  • Raymond James & Associates reported no remaining Spectranetics Corp position as of Q2 2017 after selling out during the quarter.
  • Raymond James & Associates sold 20,843 Spectranetics Corp shares in Q2 2017, an estimated $607K.
  • Raymond James & Associates first reported a position in Spectranetics Corp in Q2 2015 and held it in 3 quarters.
  • Raymond James & Associates's Spectranetics Corp position peaked at $607K in Q1 2017.
  • 170 funds tracked by Wall St. Rank held Spectranetics Corp as of Q2 2017.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.